Nov 30 2009

Raloxifene ameliorates progressive bone loss in postmenopausal dialysis patients with controlled parathyroid hormone levels.

Published by Clinical Nephrology at 4:00 pm under Uncategorized

Conclusions: Raloxifene treatment was useful for the prevention of BMD deterioration in postmenopausal dialysis patients with controlled iPTH levels.
PMID: 19954718 [PubMed - in process] (Source: Clinical Nephrology)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Comments Off

Comments are closed at this time.